Daily News Podcast

Opioids don’t top NSAIDs for chronic pain


 

Opioids’ pain relief and physical function benefits don’t top NSAIDs in chronic noncancer pain. A barbershop-based hypertension intervention is still going strong a year later. Canakinumab has a remarkable effect on knee and hip replacement risk. And low-tech BMI compares favorably with body scanning for cardiometabolic screening.

Amazon Alexa

Apple Podcasts

Google Podcasts

Spotify

Recommended Reading

FDA approval of powerful opioid tinged with irony
MDedge Rheumatology
High rates of prescription opioid, benzodiazepine use observed in chronic liver disease
MDedge Rheumatology
Careful follow-up is key in lupus psychosis
MDedge Rheumatology
Nerve growth factor antibody cuts OA pain with low AEs
MDedge Rheumatology
Pot for chronic pain? The jury is still out
MDedge Rheumatology
A case of cold burn reported with whole-body cryotherapy
MDedge Rheumatology
“FAST” indices help to identify fibromyalgia in routine rheumatology care
MDedge Rheumatology
Rheumatologist prescribing rates predict chronic opioid use in RA patients
MDedge Rheumatology
Opioid benefit small in chronic noncancer pain
MDedge Rheumatology
Insulin loses its starting spot
MDedge Rheumatology